☒ |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
|
☐ |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
|
Minnesota |
41-1597886 |
|
(State or other jurisdiction of incorporation or
organization)
|
(I.R.S. Employer Identification No.) |
1001 Third Avenue South |
||||
Minneapolis, |
Minnesota |
55404 |
||
(Address of principal executive offices) |
(Zip Code) |
Title of each class |
Trading
Symbol(s)
|
Name of each exchange on which registered |
||
Common Stock, par value $0.01 per share |
SNBR |
Nasdaq Global Select Market |
Large accelerated filer |
☐ |
Accelerated filer |
☒ |
|
Non-accelerated filer |
☐ |
Smaller reporting company |
☐ |
|
Emerging growth company |
☐ |
Page |
||
i | 3Q 2023 FORM 10-Q |
SLEEP NUMBER CORPORATION |
June 29,
2024
|
December 30,
2023
|
||
Assets |
|||
Current assets: |
|||
Cash and cash equivalents |
$2,020 |
$2,539 |
|
Accounts receivable, net of allowances of $1,098 and $1,437, respectively |
20,272 |
26,859 |
|
Inventories |
95,845 |
115,433 |
|
Prepaid expenses |
21,322 |
16,660 |
|
Other current assets |
37,925 |
44,637 |
|
Total current assets |
177,384 |
206,128 |
|
Non-current assets: |
|||
Property and equipment, net |
153,676 |
179,503 |
|
Operating lease right-of-use assets |
373,518 |
395,411 |
|
Goodwill and intangible assets, net |
66,523 |
66,634 |
|
Deferred income taxes |
25,397 |
20,253 |
|
Other non-current assets |
87,147 |
82,951 |
|
Total assets |
$883,645 |
$950,880 |
|
Liabilities and Shareholders’ Deficit |
|||
Current liabilities: |
|||
Borrowings under revolving credit facility |
$540,200 |
$539,500 |
|
Accounts payable |
106,039 |
135,901 |
|
Customer prepayments |
44,518 |
49,143 |
|
Accrued sales returns |
20,531 |
22,402 |
|
Compensation and benefits |
35,305 |
28,273 |
|
Taxes and withholding |
16,563 |
17,134 |
|
Operating lease liabilities |
80,914 |
81,760 |
|
Other current liabilities |
56,500 |
61,958 |
|
Total current liabilities |
900,570 |
936,071 |
|
Non-current liabilities: |
|||
Operating lease liabilities |
327,810 |
351,394 |
|
Other non-current liabilities |
102,229 |
105,343 |
|
Total liabilities |
1,330,609 |
1,392,808 |
|
Shareholders’ deficit: |
|||
Undesignated preferred stock; 5,000 shares authorized, no shares issued and outstanding |
— |
— |
|
Common stock, $0.01 par value; 142,500 shares authorized, 22,355 and 22,235 shares issued
and outstanding, respectively
|
224 |
222 |
|
Additional paid-in capital |
24,211 |
16,716 |
|
Accumulated deficit |
(471,399) |
(458,866) |
|
Total shareholders’ deficit |
(446,964) |
(441,928) |
|
Total liabilities and shareholders’ deficit |
$883,645 |
$950,880 |
1 | 2Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
Three Months Ended |
Six Months Ended |
||||||
June 29,
2024
|
July 1,
2023
|
June 29,
2024
|
July 1,
2023
|
||||
Net sales |
$408,413 |
$458,789 |
$878,862 |
$985,316 |
|||
Cost of sales |
166,923 |
194,544 |
361,198 |
410,806 |
|||
Gross profit |
241,490 |
264,245 |
517,664 |
574,510 |
|||
Operating expenses: |
|||||||
Sales and marketing |
182,400 |
197,779 |
390,912 |
428,267 |
|||
General and administrative |
39,573 |
39,795 |
78,652 |
79,196 |
|||
Research and development |
11,578 |
15,445 |
24,019 |
29,888 |
|||
Restructuring costs |
1,819 |
— |
12,419 |
— |
|||
Total operating expenses |
235,370 |
253,019 |
506,002 |
537,351 |
|||
Operating income |
6,120 |
11,226 |
11,662 |
37,159 |
|||
Interest expense, net |
12,270 |
9,948 |
24,569 |
19,050 |
|||
(Loss) income before income taxes |
(6,150) |
1,278 |
(12,907) |
18,109 |
|||
Income tax (benefit) expense |
(1,099) |
524 |
(374) |
5,890 |
|||
Net (loss) income |
$(5,051) |
$754 |
$(12,533) |
$12,219 |
|||
Basic net (loss) income per share: |
|||||||
Net (loss) income per share – basic |
$(0.22) |
$0.03 |
$(0.56) |
$0.55 |
|||
Weighted-average shares – basic |
22,614 |
22,460 |
22,560 |
22,378 |
|||
Diluted net (loss) income per share: |
|||||||
Net (loss) income per share – diluted |
$(0.22) |
$0.03 |
$(0.56) |
$0.54 |
|||
Weighted-average shares – diluted |
22,614 |
22,502 |
22,560 |
22,543 |
2 | 2Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
Common Stock |
Additional
Paid-in
Capital
|
Accumulated
Deficit
|
Total |
||||||
Shares |
Amount |
||||||||
Balance at December 30, 2023 |
22,235 |
$222 |
$16,716 |
$(458,866) |
$(441,928) |
||||
Net loss |
— |
— |
— |
(7,482) |
(7,482) |
||||
Stock-based compensation |
134 |
1 |
4,116 |
— |
4,117 |
||||
Repurchases of common stock |
(43) |
— |
(570) |
— |
(570) |
||||
Balance at March 30, 2024 |
22,326 |
$223 |
$20,262 |
$(466,348) |
$(445,863) |
||||
Net loss |
— |
— |
— |
(5,051) |
(5,051) |
||||
Stock-based compensation |
32 |
1 |
3,991 |
— |
3,992 |
||||
Repurchases of common stock |
(3) |
— |
(42) |
— |
(42) |
||||
Balance at June 29, 2024 |
22,355 |
$224 |
$24,211 |
$(471,399) |
$(446,964) |
Common Stock |
Additional
Paid-in
Capital
|
Accumulated
Deficit
|
Total |
||||||
Shares |
Amount |
||||||||
Balance at December 31, 2022 |
22,014 |
$220 |
$5,182 |
$(443,579) |
$(438,177) |
||||
Net income |
— |
— |
— |
11,465 |
11,465 |
||||
Exercise of common stock options |
17 |
— |
389 |
— |
389 |
||||
Stock-based compensation |
271 |
3 |
4,636 |
— |
4,639 |
||||
Repurchases of common stock |
(118) |
(1) |
(3,362) |
— |
(3,363) |
||||
Balance at April 1, 2023 |
22,184 |
$222 |
$6,845 |
$(432,114) |
$(425,047) |
||||
Net income |
— |
— |
— |
754 |
754 |
||||
Exercise of common stock options |
3 |
— |
39 |
— |
39 |
||||
Stock-based compensation |
33 |
— |
5,251 |
— |
5,251 |
||||
Repurchases of common stock |
(6) |
— |
(138) |
— |
(138) |
||||
Balance at July 1, 2023 |
22,214 |
$222 |
$11,997 |
$(431,360) |
$(419,141) |
3 | 2Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
Six Months Ended |
|||
June 29,
2024
|
July 1,
2023
|
||
Cash flows from operating activities: |
|||
Net (loss) income |
$(12,533) |
$12,219 |
|
Adjustments to reconcile net (loss) income to net cash provided by
operating activities:
|
|||
Depreciation and amortization |
34,177 |
36,749 |
|
Stock-based compensation |
8,109 |
9,890 |
|
Net loss on disposals and impairments of assets |
2,500 |
181 |
|
Deferred income taxes |
(5,144) |
(8,272) |
|
Changes in operating assets and liabilities: |
|||
Accounts receivable |
6,587 |
1,903 |
|
Inventories |
19,588 |
(7,412) |
|
Income taxes |
774 |
1,808 |
|
Prepaid expenses and other assets |
(1,483) |
(5,824) |
|
Accounts payable |
(18,464) |
(10,244) |
|
Customer prepayments |
(4,625) |
(14,683) |
|
Accrued compensation and benefits |
7,153 |
7,594 |
|
Other taxes and withholding |
(1,345) |
(2,074) |
|
Other accruals and liabilities |
(11,776) |
(3,115) |
|
Net cash provided by operating activities |
23,518 |
18,720 |
|
Cash flows from investing activities: |
|||
Purchases of property and equipment |
(14,075) |
(29,899) |
|
Issuance of note receivable |
(2,942) |
(435) |
|
Net cash used in investing activities |
(17,017) |
(30,334) |
|
Cash flows from financing activities: |
|||
Net (decrease) increase in short-term borrowings |
(6,408) |
14,693 |
|
Repurchases of common stock |
(612) |
(3,501) |
|
Proceeds from issuance of common stock |
— |
428 |
|
Net cash (used in) provided by financing activities |
(7,020) |
11,620 |
|
Net (decrease) increase in cash and cash equivalents |
(519) |
6 |
|
Cash and cash equivalents, at beginning of period |
2,539 |
1,792 |
|
Cash and cash equivalents, at end of period |
$2,020 |
$1,798 |
4 | 2Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
5 | 2Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
June 29,
2024
|
December 30,
2023
|
||
Raw materials |
$7,899 |
$9,092 |
|
Work in progress |
94 |
92 |
|
Finished goods |
87,852 |
106,249 |
|
$95,845 |
$115,433 |
2024 (excluding the six months ended June 29, 2024) |
$111 |
|
2025 |
226 |
|
2026 |
222 |
|
2027 |
222 |
|
2028 |
155 |
|
2029 |
99 |
|
Thereafter |
46 |
|
Total future amortization for definite-lived intangible assets |
$1,081 |
6 | 2Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
June 29,
2024
|
December 30,
2023
|
||
Outstanding borrowings |
$540,200 |
$539,500 |
|
Outstanding letters of credit |
$7,147 |
$7,147 |
|
Additional borrowing capacity |
$132,653 |
$138,353 |
|
Weighted-average interest rate |
8.4% |
8.5% |
7 | 2Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
Three Months Ended |
Six Months Ended |
||||||
June 29,
2024
|
July 1,
2023
|
June 29,
2024
|
July 1,
2023
|
||||
Operating lease costs(1) |
$26,909 |
$28,083 |
$53,735 |
$56,372 |
|||
Variable lease costs(2) |
$8 |
$129 |
$(41) |
$182 |
2024 (excluding the six months ended June 29, 2024) |
$53,107 |
2025 |
100,672 |
2026 |
88,780 |
2027 |
72,728 |
2028 |
60,841 |
2029 |
41,075 |
Thereafter |
71,244 |
Total operating lease payments(2) |
488,447 |
Less: Interest |
79,723 |
Present value of operating lease liabilities |
$408,724 |
June 29,
2024
|
December 30,
2023
|
|||
Weighted-average remaining lease term (in years) |
5.7 |
5.9 |
||
Weighted-average discount rate |
6.6% |
6.5% |
Six Months Ended |
||||
(in thousands) |
June 29,
2024
|
July 1,
2023
|
||
Cash paid for amounts included in present value of operating lease liabilities |
$54,300 |
$53,476 |
||
Right-of-use assets obtained in exchange for operating lease liabilities |
$16,313 |
$32,831 |
8 | 2Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
June 29,
2024
|
December 30,
2023
|
||
Deferred contract assets included in: |
|||
Other current assets |
$29,771 |
$28,567 |
|
Other non-current assets |
52,312 |
54,795 |
|
$82,083 |
$83,362 |
June 29,
2024
|
December 30,
2023
|
||
Deferred contract liabilities included in: |
|||
Other current liabilities |
$37,720 |
$36,421 |
|
Other non-current liabilities |
65,362 |
69,098 |
|
$103,082 |
$105,519 |
Three Months Ended |
Six Months Ended |
||||||
June 29,
2024
|
July 1,
2023
|
June 29,
2024
|
July 1,
2023
|
||||
Retail stores |
$358,584 |
$402,145 |
$773,339 |
$860,808 |
|||
Online, phone, chat and other |
49,829 |
56,644 |
105,523 |
124,508 |
|||
Total Company |
$408,413 |
$458,789 |
$878,862 |
$985,316 |
Six Months Ended |
|||
June 29,
2024
|
July 1,
2023
|
||
Balance at beginning of year |
$22,402 |
$25,594 |
|
Additions that reduce net sales |
46,664 |
57,849 |
|
Deductions from reserves |
(48,535) |
(57,967) |
|
Balance at end of period |
$20,531 |
$25,476 |
9 | 2Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
Three Months Ended |
Six Months Ended |
||||||
June 29,
2024
|
July 1,
2023
|
June 29,
2024
|
July 1,
2023
|
||||
Stock awards (1) |
$3,294 |
$4,258 |
6,438 |
$8,113 |
|||
Stock options |
698 |
994 |
1,671 |
1,777 |
|||
Total stock-based compensation expense (1) |
3,992 |
5,252 |
8,109 |
9,890 |
|||
Income tax benefit |
809 |
1,417 |
1,719 |
2,670 |
|||
Total stock-based compensation expense,
net of tax
|
$3,183 |
$3,835 |
$6,390 |
$7,220 |
Three Months Ended |
Six Months Ended |
||||||
June 29,
2024
|
July 1,
2023
|
June 29,
2024
|
July 1,
2023
|
||||
Net (loss) income |
$(5,051) |
$754 |
$(12,533) |
$12,219 |
|||
Reconciliation of weighted-average shares outstanding: |
|||||||
Basic weighted-average shares outstanding |
22,614 |
22,460 |
22,560 |
22,378 |
|||
Dilutive effect of stock-based awards |
— |
42 |
— |
165 |
|||
Diluted weighted-average shares outstanding |
22,614 |
22,502 |
22,560 |
22,543 |
|||
Net (loss) income per share – basic |
$(0.22) |
$0.03 |
$(0.56) |
$0.55 |
|||
Net (loss) income per share – diluted |
$(0.22) |
$0.03 |
$(0.56) |
$0.54 |
10 | 2Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
Three Months Ended |
Six Months Ended |
||
June 29,
2024
|
June 29,
2024
|
||
Cash restructuring costs: |
|||
Contract termination costs (1) |
$(230) |
$4,183 |
|
Severance and employee-related benefits |
401 |
1,242 |
|
Professional fees and other |
1,648 |
4,494 |
|
Total cash restructuring costs |
1,819 |
9,919 |
|
Non-cash restructuring costs: |
|||
Asset impairments (2) |
— |
2,500 |
|
Total restructuring costs |
$1,819 |
$12,419 |
Six Months Ended |
|||
June 29,
2024
|
|||
Balance at the beginning of year |
$8,720 |
||
Expenses |
9,919 |
||
Cash payments |
(16,916) |
||
Balance at the end of the period |
$1,723 |
11 | 2Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
Cumulative |
||
June 29,
2024
|
||
Cash restructuring costs: |
||
Contract termination costs (1) |
$11,593 |
|
Severance and employee-related benefits |
6,208 |
|
Professional fees and other |
5,604 |
|
Total cash restructuring costs |
23,405 |
|
Non-cash restructuring costs: |
||
Asset impairments (2) |
4,742 |
|
Total restructuring costs |
$28,147 |
Six Months Ended |
|||
June 29,
2024
|
July 1,
2023
|
||
Balance at beginning of period |
$8,503 |
$8,997 |
|
Additions charged to costs and expenses for current-year sales |
7,675 |
8,194 |
|
Deductions from reserves |
(8,048) |
(8,315) |
|
Changes in liability for pre-existing warranties during the current year, including
expirations
|
(171) |
111 |
|
Balance at end of period |
$7,959 |
$8,987 |
12 | 2Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
13 | 2Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
14 | 2Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
15 | 2Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
16 | 2Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
17 | 2Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
Three Months Ended |
Six Months Ended |
||||||||||||||
June 29,
2024
|
July 1,
2023
|
June 29,
2024
|
July 1,
2023
|
||||||||||||
Net sales |
$408.4 |
100.0% |
$458.8 |
100.0% |
$878.9 |
100.0% |
$985.3 |
100.0% |
|||||||
Cost of sales |
166.9 |
40.9% |
194.5 |
42.4% |
361.2 |
41.1% |
410.8 |
41.7% |
|||||||
Gross profit |
241.5 |
59.1% |
264.3 |
57.6% |
517.7 |
58.9% |
574.5 |
58.3% |
|||||||
Operating expenses: |
|||||||||||||||
Sales and marketing |
182.4 |
44.7% |
197.8 |
43.1% |
390.9 |
44.5% |
428.3 |
43.5% |
|||||||
General and administrative |
39.6 |
9.7% |
39.8 |
8.7% |
78.7 |
8.9% |
79.2 |
8.0% |
|||||||
Research and development |
11.6 |
2.8% |
15.4 |
3.4% |
24.0 |
2.7% |
29.9 |
3.0% |
|||||||
Restructuring costs |
1.8 |
0.4% |
— |
0.0% |
12.4 |
1.4% |
— |
0.0% |
|||||||
Total operating expenses |
235.4 |
57.6% |
253.0 |
55.1% |
506.0 |
57.6% |
537.4 |
54.5% |
|||||||
Operating income |
6.1 |
1.5% |
11.2 |
2.4% |
11.7 |
1.3% |
37.2 |
3.8% |
|||||||
Interest expense, net |
12.3 |
3.0% |
9.9 |
2.2% |
24.6 |
2.8% |
19.1 |
1.9% |
|||||||
(Loss) income before income
taxes
|
(6.2) |
(1.5%) |
1.3 |
0.3% |
(12.9) |
(1.5%) |
18.1 |
1.8% |
|||||||
Income tax (benefit) expense |
(1.1) |
(0.3%) |
0.5 |
0.1% |
(0.4) |
0.0% |
5.9 |
0.6% |
|||||||
Net (loss) income |
$(5.1) |
(1.2%) |
$0.8 |
0.2% |
$(12.5) |
(1.4%) |
$12.2 |
1.2% |
|||||||
Net (loss) income per share: |
|||||||||||||||
Basic |
$(0.22) |
$0.03 |
$(0.56) |
$0.55 |
|||||||||||
Diluted |
$(0.22) |
$0.03 |
$(0.56) |
$0.54 |
|||||||||||
Weighted-average number of common shares: |
|||||||||||||||
Basic |
22.6 |
22.5 |
22.6 |
22.4 |
|||||||||||
Diluted |
22.6 |
22.5 |
22.6 |
22.5 |
Three Months Ended |
Six Months Ended |
||||||
June 29,
2024
|
July 1,
2023
|
June 29,
2024
|
July 1,
2023
|
||||
Retail stores |
87.8% |
87.7% |
88.0% |
87.4% |
|||
Online, phone, chat and other |
12.2% |
12.3% |
12.0% |
12.6% |
|||
Total Company |
100.0% |
100.0% |
100.0% |
100.0% |
18 | 2Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
Three Months Ended |
Six Months Ended |
||||||
June 29,
2024
|
July 1,
2023
|
June 29,
2024
|
July 1,
2023
|
||||
Sales change rates: |
|||||||
Retail comparable-store sales (1) |
(11%) |
(20%) |
(10%) |
(10%) |
|||
Online, phone and chat |
(13%) |
(3%) |
(16%) |
(12%) |
|||
Total Retail comparable sales change (1) |
(11%) |
(18%) |
(11%) |
(10%) |
|||
Net opened/closed stores and other |
0% |
2% |
0% |
2% |
|||
Total Company |
(11%) |
(16%) |
(11%) |
(8%) |
Three Months Ended |
Six Months Ended |
||||||
June 29,
2024
|
July 1,
2023
|
June 29,
2024
|
July 1,
2023
|
||||
Average sales per store (1) (in thousands) |
$2,732 |
$3,089 |
|||||
Average sales per square foot (1) |
$883 |
$1,007 |
|||||
Stores > $2 million in net sales (2) |
62% |
71% |
|||||
Stores > $3 million in net sales (2) |
21% |
31% |
|||||
Average revenue per smart bed unit (3) |
$5,802 |
$5,990 |
$5,782 |
$5,913 |
Three Months Ended |
Six Months Ended |
||||||
June 29,
2024
|
July 1,
2023
|
June 29,
2024
|
July 1,
2023
|
||||
Beginning of period |
661 |
671 |
672 |
670 |
|||
Opened |
4 |
7 |
10 |
19 |
|||
Closed |
(19) |
(6) |
(36) |
(17) |
|||
End of period |
646 |
672 |
646 |
672 |
19 | 2Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
20 | 2Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
21 | 2Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
22 | 2Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
Six Months Ended |
|||
June 29,
2024
|
July 1,
2023
|
||
Total cash provided by (used in): |
|||
Operating activities |
$23.5 |
$18.7 |
|
Investing activities |
(17.0) |
(30.3) |
|
Financing activities |
(7.0) |
11.6 |
|
Net (decrease) increase in cash and cash equivalents |
$(0.5) |
$0.0 |
23 | 2Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
Three Months Ended |
Trailing-Twelve
Months Ended
|
||||||
June 29,
2024
|
July 1,
2023
|
June 29,
2024
|
July 1,
2023
|
||||
Net (loss) income |
$(5,051) |
$754 |
$(40,039) |
$11,822 |
|||
Income tax (benefit) expense |
(1,099) |
524 |
(10,730) |
6,602 |
|||
Interest expense |
12,270 |
9,948 |
48,214 |
32,289 |
|||
Depreciation and amortization |
16,347 |
18,304 |
69,676 |
71,318 |
|||
Stock-based compensation |
3,992 |
5,252 |
13,073 |
15,071 |
|||
Restructuring costs |
1,819 |
— |
28,147 |
— |
|||
Asset impairments |
— |
170 |
490 |
294 |
|||
Adjusted EBITDA |
$28,278 |
$34,952 |
$108,831 |
$137,396 |
Six Months Ended |
Trailing-Twelve
Months Ended
|
||||||
June 29,
2024
|
July 1,
2023
|
June 29,
2024
|
July 1,
2023
|
||||
Net cash provided by (used in) operating
activities
|
$23,518 |
$18,720 |
$(4,230) |
$26,167 |
|||
Subtract: Purchases of property and
equipment
|
14,075 |
29,899 |
41,232 |
62,794 |
|||
Free cash flow |
$9,443 |
$(11,179) |
$(45,462) |
$(36,627) |
24 | 2Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
Trailing-Twelve Months Ended |
|||
June 29,
2024
|
July 1,
2023
|
||
Adjusted net operating profit after taxes (Adjusted NOPAT) |
|||
Operating (loss) income |
$(2,555) |
$50,713 |
|
Add: Operating lease expense (1) |
27,750 |
27,040 |
|
Less: Income taxes (2) |
(6,104) |
(21,993) |
|
Adjusted NOPAT |
$19,091 |
$55,760 |
|
Average adjusted invested capital |
|||
Total deficit |
$(446,964) |
$(419,141) |
|
Add: Long-term debt (3) |
540,480 |
484,161 |
|
Add: Operating lease obligations (4) |
408,724 |
438,483 |
|
Total adjusted invested capital at end of period |
$502,240 |
$503,503 |
|
Average adjusted invested capital (5) |
$509,369 |
$452,573 |
|
Adjusted return on invested capital (Adjusted ROIC) (6) |
3.7% |
12.3% |
25 | 2Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
26 | 2Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
27 | 2Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
Period |
Total
Number
of Shares
Purchased(1)(2)
|
Average
Price
Paid per
Share
|
Total Number
of
Shares
Purchased
as Part of
Publicly
Announced
Plans
or Programs(1)
|
Approximate
Dollar Value of
Shares that May
Yet Be Purchased
Under the Plans
or Programs(3)
|
||||
March 31, 2024 through April 27, 2024 |
1,320 |
$13.28 |
— |
$348,071,000 |
||||
April 28, 2024 through May 25, 2024 |
1,096 |
$15.96 |
— |
$348,071,000 |
||||
May 26, 2024 through June 29, 2024 |
588 |
$12.60 |
— |
$348,071,000 |
||||
Total |
3,004 |
$14.13 |
— |
$348,071,000 |
28 | 2Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
Exhibit
Number
|
Description |
|
10.1† |
||
31.1* |
||
31.2* |
||
32.1* |
||
32.2* |
||
101.INS* |
Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File
because its XBRL tags are embedded within the Inline XBRL document
|
|
101.SCH* |
Inline XBRL Taxonomy Extension Schema Document |
|
101.CAL* |
Inline XBRL Taxonomy Extension Calculation Linkbase Document |
|
101.DEF* |
Inline XBRL Taxonomy Extension Definition Linkbase Document |
|
101.LAB* |
Inline XBRL Taxonomy Extension Label Linkbase Document |
|
101.PRE* |
Inline XBRL Taxonomy Extension Presentation Linkbase Document |
|
104* |
Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101) |
29 | 2Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
SLEEP NUMBER CORPORATION |
|||
(Registrant) |
|||
Dated: |
August 6, 2024 |
By: |
/s/ Shelly R. Ibach |
Shelly R. Ibach |
|||
Chief Executive Officer |
|||
(principal executive officer) |
|||
By: |
/s/ Joel J. Laing |
||
Joel J. Laing |
|||
Chief Accounting Officer |
|||
(principal accounting officer) |
30 | 2Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
Date: August 6, 2024 | |||||
/s/ Shelly R. Ibach | |||||
Shelly R. Ibach | |||||
Chief Executive Officer |
Date: August 6, 2024 | |||||
/s/ Francis K. Lee | |||||
Francis K. Lee | |||||
Executive Vice President and Chief Financial Officer |
Date: August 6, 2024 | |||||
/s/ Shelly R. Ibach | |||||
Shelly R. Ibach | |||||
Chief Executive Officer |
Date: August 6, 2024 | |||||
/s/ Francis K. Lee | |||||
Francis K. Lee | |||||
Executive Vice President and Chief Financial Officer |